1. Corporate Officers - R
2. Robertson Michelle

Insider Trading History of Robertson Michelle

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Robertson Michelle since 2019. This trader's CIK number is 1755098. At the time of last reporting, Robertson Michelle was the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc.. (stock ticker symbol EDIT). Also see all insider trading activities at Editas Medicine, Inc..

Note that in the past ROBERTSON MICHELLE also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Robertson Michelle

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	MNTA	0	$0	10,441	$151,843	9,750	$0

Yearly summary of insider trading at Editas Medicine, Inc. (EDIT) by Robertson Michelle

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	EDIT	0	$0	7,172	$66,732	0	$0
2022	EDIT	0	$0	4,038	$75,726	0	$0
2021	EDIT	0	$0	4,068	$272,727	2,500	$76,625

Insider trading activities at 2 companies by Robertson Michelle:

1. Momenta Pharmaceuticals Inc (MNTA)

2. Editas Medicine, Inc. (EDIT)

Table 1. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Robertson Michelle

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-10-25	MNTA	Sale	6,802	15.00	102,030
2019-10-18	MNTA	Sale	2,936	13.83	40,604
2019-10-17	MNTA	Option Ex	9,750	.00	0
2019-02-14	MNTA	Sale	703	13.10	9,209

Table 2. Insider trading of Editas Medicine, Inc. (EDIT) by Robertson Michelle

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-05-11	EDIT	Sale	949	9.87	9,368
2023-03-03	EDIT	Sale	184	8.89	1,635
2023-02-13	EDIT	Sale	4,287	9.66	41,433
2023-01-10	EDIT	Sale	1,752	8.16	14,296
2022-06-03	EDIT	Sale	1,527	11.54	17,616
2022-03-03	EDIT	Sale	767	17.33	13,290
2022-01-11	EDIT	Sale	1,744	25.70	44,820
2021-08-09	EDIT	Option Ex	2,500	30.65	76,625
2021-08-09	EDIT	Sale	2,500	60.00	150,000
2021-01-12	EDIT	Sale	1,568	78.27	122,727

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robertson Michelle (EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month